Elanco Animal Health Inc
NYSE:ELAN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.78
18.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Elanco Animal Health Inc
Net Margin
Elanco Animal Health Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | US |
| Market Cap | 6.5B USD |
| Net Margin |
5%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 749.7B USD |
| Net Margin |
20%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | DK |
| Market Cap | 3.4T DKK |
| Net Margin |
35%
|
| Country | US |
| Market Cap | 372B USD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 257.3B USD |
| Net Margin |
19%
|
| Country | CH |
| Market Cap | 200.4B CHF |
| Net Margin |
20%
|
| Country | UK |
| Market Cap | 162.7B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 179.9B CHF |
| Net Margin |
35%
|
| Country | IE |
| Market Cap | 146B USD |
| Net Margin |
-126%
|
Elanco Animal Health Inc
Glance View
Elanco Animal Health Inc. has emerged as a leading player in the global animal health industry, driven by a commitment to improving the health and productivity of livestock and pets alike. With a history that dates back to the late 1950s, Elanco operates under the guiding principle that healthy animals lead to healthy societies, making their mission not just a business goal but a moral imperative. The company's expansive portfolio includes vaccines, parasiticides, antibiotics, and nutritional products, which cater to a diverse range of species including cattle, pigs, and companion animals. By leveraging cutting-edge research and development, Elanco continually innovates to address emerging challenges in animal health, such as antibiotic resistance and the demand for sustainable farming practices, thereby aligning itself with broader societal health agendas. For investors, Elanco presents a compelling opportunity anchored in robust financial performance and a resilient business model. The company's strategic acquisitions have bolstered its market presence, particularly following the acquisition of Bayer’s Animal Health business, which significantly expanded its product offerings and revenue base. Additionally, Elanco has demonstrated strong growth potential, driven by increasing global demand for protein and the human-animal bond that fuels spending on pet care. With a seasoned management team and a focus on sustainability and innovation, Elanco is well-positioned to capitalize on market trends while delivering value to shareholders. As the world navigates the complexities of food security and animal welfare, Elanco stands out as both a growth story and a responsible investment in the future of health.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Elanco Animal Health Inc's most recent financial statements, the company has Net Margin of 4.6%.
You don't have any saved screeners yet
